1523 results about "High Blood Pressures" patented technology

Devices, systems and methods are disclosed for the formation of an arteriovenous fistula. Embodiments include catheter apparatus including an ablation element for creating and/or modifying the fistula. The devices, systems and methods can be used to treat patients with one or more numerous ailments including chronic obstructive pulmonary disease, congestive heart failure, hypertension, hypotension, respiratory failure, pulmonary arterial hypertension, lung fibrosis and adult respiratory distress syndrome.

The invention provides a method of treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance) in a mammal by administering to the mammal a therapeutically effective amount of an irreversible MAO-B inhibitor.

The present invention is generally related to the discovery of the therapeutic benefit of administering gamma-tocopherol and gamma-tocopherol derivatives. More specifically, the use of gamma-tocopherol and racemic LLU-alpha, (S)-LLU-alpha, or gamma-tocopherol derivatives as antioxidants and nitrogen oxide scavengers which treat and prevent high blood pressure, thromboembolic disease, cardiovascular disease, cancer, natriuretic disease, the formation of neuropathological lesions, and a reduced immune system response are disclosed.

The object of the present invention is to provide PPAR (peroxisome proliferator-activated receptor) activity regulators, which can be widely used for improving insulin resistance and preventing/treating various diseases such as diabetes, metabolic syndromes, hyperlipemia, high-blood pressure, vascular disorders, inflammation, hepatitis, fatty liver, liver fibrosis, NASH (non-alcoholic steatohepatitis) and obesity.

The present invention provides PPAR activity regulators which comprise an acylamide compound having the specific structure, prodrugs thereof, or pharmaceutically acceptable salts thereof.

The present invention provides novel compounds of Formula I

and salts, hydrates, solvates, complexes, and prodrugs thereof. The present invention further provides methods for synthesizing compounds of Formula I. The invention additionally provides pharmaceutical compositions comprising the compounds of Formula I and methods of using the pharmaceutical compositions of Formula I to treat and prevent disorders and diseases associated with the RyR receptors that regulate calcium channel functioning in cells. Such disorders and diseases include, by way of example only, cardiac disorders and diseases, skeletal muscular disorders and diseases, cognitive disorders and diseases, malignant hyperthermia, diabetes, and sudden infant death syndrome. Cardiac disorder and diseases include, but are not limited to, irregular heartbeat disorders and diseases; exercise-induced irregular heartbeat disorders and diseases; sudden cardiac death; exercise-induced sudden cardiac death; congestive heart failure; chronic obstructive pulmonary disease; and high blood pressure. Irregular heartbeat disorders and diseases include and exercise-induced irregular heartbeat disorders and diseases include, but are not limited to, atrial and ventricular arrhythmia; atrial and ventricular fibrillation; atrial and ventricular tachyarrhythmia; atrial and ventricular tachycardia; catecholaminergic polymorphic ventricular tachycardia (CPVT); and exercise-induced variants thereof. Skeletal muscular disorder and diseases include, but are not limited to, skeletal muscle fatigue, exercise-induced skeletal muscle fatigue, muscular dystrophy, bladder disorders, and incontinence. Cognitive disorders and diseases include, but are not limited to, Alzheimer's Disease, forms of memory loss, and age-dependent memory loss.

The invention provides a sleep-improving and health-care drug pillow, relating to a health-care medical product, in particular to making materials and process of the sleep-improving and health-care drug pillow. A drug core of the pillow mainly comprises the following raw materials in parts by weight: 1000 parts of cottonseeds, 500 parts of buckwheat shell, 20 parts of tea, 30 parts of spina date seed, 30 parts of schisandra, 20 parts of lily, 20 parts of ganoderma lucidum, 30 parts of akebia stem, 30 parts of tuber fleeceflower root, 10 parts of cordyceps, 10 parts of Chinese angelica, 30 parts of rehmannia root, 10 parts of safflower, 30 parts of red-rooted salvia root, 10 parts of longan, 30 parts of common clubmoss herb, 30 parts of garden balsam stem, 10 parts of Chinese atractylode rhizome, 10 parts of clematis root, 30 parts of pawpaw, 30 parts of divaricate saposhnikovia root, 30 parts of dried orange peel, 20 parts of costustoot, 20 parts of polygala root, 30 parts of Szechwan lovage rhizome, 10 parts of honeysuckle, 20 parts of glossy privet fruit, 10 parts of wild chrysanthemum, 10 parts of lonicera chrysantha flower, 10 parts of amomum shell, 20 parts of mint, 30 parts of galanga, 20 parts of bergamot, 20 parts of coptis, 20 parts of amur corktree bark, 10 parts of tuber fleeceflower stem, 10 parts of dwarf lilytruf tuber, 10 parts of dandelion, 30 parts of radix astragali, 30 parts of nutgrass galingale rhizome, 2000 parts of millet mature vinegar, 30 parts of honey and 30 parts of yellow wine and is refined by adopting the processes of soaking, roasting, brewing, mixing and the like. The sleeping-improving and health-care pillow has the advantages of simple making process and strong drug efficacy and has special curative effects on long-term insomnia, high blood pressure, headache, tinnitus and cervical pain.

A multi-colored health care tofu containing fruit and vegetable comprises the following raw materials with the weight portions of 8 to 10 portions of soybean, 4 to 10 portions of fruits, 8 to 10 portions of vegetables and 0.3 to 1 portions of ecological coagulant, wherein, the fruit and the vegetable are the fruits and the vegetables with the pH of less than 7. The ecological coagulant is the mixture of glucose and plaster which is in the ratio of 1 to 3:22 to 28. The production process comprises screening and sorting soybean, soaking and removing peels, grinding for separation, mixing and coloring by adding the extracted natural vegetable juice and fruit juice, cooking and coagulating, squeezing and forming and packing the finished products. In the invention, algin, mannite, plant fiber, protein, a plurality of amino acids, a plurality of vitamins, a plurality of trace elements including calcium, iron and selenium which are the essential matter inside the body are added, which can effectively prevent a plurality of diseases including high blood pressure, obesity, cardiovascular genomic, biliary calculus and other diseases.

The invention discloses an agent box, which is characterized by the following: utilizing the relation between mononucleotide polymorphism site E112D genetype of important enzyme praline carboxypeptidase gene on vessel or esoderma regulating access and ACEI medical effect; forecasting ACEI medical effect; possessing good ACEI medical effect when genetype as 112EE pure wild-type; possessing bad effect when the genetype as 112ED heterozygous type or 112DD pure saltant; incorporating polymorphism parting oligonucleotide of E112D polymorphism site genetype with praline carboxypeptidase gene to test biological sample and related agent. This invention improves effectiveness and safety of clinic medicine, which provides criterion for new medicine of high blood pressure.

The invention discloses a preparation method for highly effective compound dietary cellulose. The method of the invention is characterized in that: the highly effective compound dietary cellulose is prepared with the following materials, insoluble dietary fiber, water-soluble dietary fiber, vitamin C and lactic acid bacteria powder, in definite proportions. The product of the invention is the highly effective compound dietary cellulose which is provided with dual characteristics of insoluble dietary fiber and water-soluble dietary fiber and the dosage form of the product can be capsules or granules. The long-term taking of the product of the invention can ensure obvious curative effects on high blood pressure, high blood fat, high cholesterol, diabetes, obesity, constipation, gastro-intestinal diseases, etc. If being added with different materials such as microcrystalline celluloses, magnesium stearate, maltodextrin, citric acid, sodium bicarbonate and PEG6000, according to different preparation forms, the product can also be prepared into tablets, chewable tablets and effervescent tablets. The highly effective compound dietary cellulose of the invention has simple, scientific and reasonable prescription, simple technology and stable quality, and is easy to be produced in large scale, thus being a safe and green health-care food product.

Dependent variables believed to contribute to a likelihood of falling are analyzed using a latent class analysis. The dependent variables are biomedical factors, which may include, for example, arthritis, high blood pressure, diabetes, foot disorders, Parkinson's Disease, stroke, eye disorder, limb disorder, or proprioceptive disorder. Data pertaining to the biomedical factors is gathered from a population of individuals at risk of falling. Covariate data, including for example age and the number of prescriptions taken, is further analyzed against latent class data. For a particular group of at risk individuals, a set of five classes produced useful results broadly corresponding to groups representing individuals who have: good health; a range of diseases; Parkinson's Disease; arthritis; and high blood pressure. A probability of falling is determined, relative to the group of individuals with good health.

Food products fortified with a therapeutically effective amount of milk mineral are administered for the treatment of high blood pressure, stroke, obesity, kidney stones, colon cancer, breast cancer, head and neck tumors, premenstrual syndrome, postpartum depression, hypertensive disorders of pregnancy, Type-2 diabetes, depression, asthma, inflammatory bowel disease, attention deficit disorder, migraine headaches, kidney disease, hypercholesterolaemia, congestive heart failure, or immune deficiency.

The invention discloses a non-invasive central aortic blood pressure measuring method and device. The non-invasive central aortic blood pressure measuring method includes, according to a human artery network model based on viscous fluid mechanics, a method of calculating artery network model personalized parameters of a measured person through measured radial artery and brachial artery pulse wave signals and arm blood pressure values, a method of calculating an ascending aorta-radial artery transfer function and a method of calculating central arterial pressure waveforms through measured central arterial pressures. The non-invasive central aortic blood pressure continuous measuring device comprises a pulse wave signal processing and analysis unit and a radial artery and brachial artery pulse wave signal acquisition unit worn on a wrist. The method is different from an existing general transfer function method, the artery network model parameters of each person to be measured are measured and calculated and the artery network model parameters are numerical characteristics of the cardiovascular system states of the person to be measured with the calculated central arterial pressure waveforms, and the method and device has important meanings in prevention, curing and control of cardiovascular diseases, especially high-risk diseases, such as hypertensions and coronary heart diseases.

Surgical methods of and kits for applying and stabilizing a mass of fibrin sealant or platelet concentrate at the site of surgical attachment of an implantable medical device to effect hemostasis to stem internal bleeding at the site of surgical attachment are disclosed. A mass of fibrin sealant or platelet concentrate is applied onto a porous fabric, whereby the mass is supported in the interstices or pores of the fabric, and the supported mass is applied against the site of high pressure blood leakage. The supported mass achieves hemostasis as it does not wash away from the site. The present invention is particularly useful to effect hemostasis at sutures and suture holes extending through thin-walled tissue valves and grafts when such tissue valves or grafts are sutured in place, particularly at high blood pressure sites as at the valve annulus of the aortic valve or the aorta.

The present invention relates to the unexpected discovery that a combination of effective amounts of carnitine (in any form, as described in further detail herein) and conjugated linoleic acid (CLA) administered to a patient in need thereof exhibits synergistic activity in treating obesity by reducing fat mass and overall weight as well as one or more of hyperlipidemia, hypercholesterolemia, diabetes (both diabetes mellitus I and II), metabolic syndrome (syndrome X), kidiney failure and high blood pressure, where those conditions exist.

The invention relates to a method of administering to a human subject a composition comprising a vitamin, an amino acid and a trace element for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body like high blood pressure, asthma, glaucoma and tinnitus. The composition comprises a vitamin such as ascorbic acid, an amino acid such as arginine, and a trace element such as magnesium.

The present invention provides methods and apparatuses to assess vascular stiffness of a subject, and to assess diabetes or hypertension from the assessment of vascular stiffness. Example embodiments comprise determining arrival at a peripheral site of a blood pressure wave as a function of time relative to the cardiac cycle of the subject at a plurality of measurement conditions, wherein at least two of the conditions are characterized by at least one of: (a) different central transmural pressure, (b) different peripheral transmural pressure; assessing vascular stiffness from the determinations at the plurality of measurement conditions.

Correlations between polymorphisms and metabolic syndrome, insulin resistance, obesity, high blood pressure, dyslipidemia, diabetes and/or myocardial infarction are provided. Methods of diagnosing and treating metabolic syndrome, insulin resistance, obesity, high blood pressure, dyslipidemia, diabetes and/or myocardial infarction are provided. Systems and kits for diagnosis and treatment of metabolic syndrome, insulin resistance, obesity, high blood pressure, dyslipidemia, diabetes and/or myocardial infarction are provided.

The invention relates to a gene chip used for detecting gene mutation relating to a high blood pressure personalized medicine. The gene chip for detecting the gene mutation relating to high blood pressure personalized medicine comprises a solid phase support, a gene probe (an oligonueleotide probe) fixed in the solid phase support sequentially and a PCR primer used for amplifying the mutated gene fragment in the sample; the gene probe (the oligonueleotide probe) and the PCR primer are designed aiming at one or two points of the gene mutation in ACE (I/D) and CYP3A5*3 and / or two or more points as follows: CYP2C9*3, CYP2C9*13, AGTR1(A1166C), CYP2D6*10, ADRB1(C1165G), TSC(C1784T), ADRB3(T727C), SCNN1G_rs5729, SCNN1G_rs5723, ENOSA_rs1799983 and GNB3(C825T). The invention provides the gene chip and applications thereof for conveniently, quickly and systematically detecting the gene mutation relating to high blood pressure personalized medicine so as to determine drug reactions.

The invention provides a pharmacy acceptable salt type of imidazole-5-carboxyl acid derivative, a relative preparation method and a drug compound. The inventive salt has good solubility in general solvent as water and methanol, good biological availability in animal body and the application for developing general agent to treat high blood pressure.

The invention discloses liquid-lowering health cookie. The liquid-lowering health cookie is made with, by weigh, 100-110 parts of flour, 40-50 parts of natto, 20-30 parts of mung bean powder, 1-2 parts of lotus leaf, 1-3 parts of Kuding, 2-3 parts of pubescent holly root, 1-2 parts of suberect spatholobus stem, 15-20 parts of broccoli, 10-14 parts of bamboo shoot, 8-12 parts of Chinese Mesona herb, 12-15 parts of wax apple, 20-30 parts of codfish, 5-8 parts of salt, 1-2 parts of cookie additive, and the proper amount of water. The natto added to the liquid-lowering health cookie is rich in protein, cellulose, calcium, iron and the like, and has the effects of thrombolysis, tumor suppression, blood pressure lowering, blood lipid lowering, oxidation resistance, osteoporosis prevention, blood clotting promotion and the like. The wax apple is a fine fruit for treating various diseases, has sweet taste and neutral nature, and has the effects of moistening lung, suppressing cough, eliminating phlegm, cooling blood, and astringing. The Chinese Mesona herb has the effects of clearing summer heat and cooling to excrete water, and has good therapeutic effect on hypertension, kidney diseases, diabetes, joint muscular pain and the like. The Kuding has the effects of clearing summer heat, improving eyesight and promoting intelligence, helping produce saliva and slake thirst, lowering blood lipid, preventing cancer and senescence, invigorating blood vessels and the like.

The invention discloses cyclocarya paliurus bean curd which is prepared from soybean milk, fresh green ocarya paliurus leave juice and fresh green ocarya paliurus leave powder. The weight ratio of the soybean milk to the fresh green ocarya paliurus leave juice is 1:(0.06-0.12), and the weight ratio of the soybean milk to the fresh green ocarya paliurus leave powder is 1:(0.02-0.05). The process for preparing the cyclocarya paliurus bean curd comprises the following steps: preparing a mixed syrup according to the adding proportion of 100:(6-12):(2-5) of the soybean milk, the fresh green ocarya paliurus leave juice and hefresh green ocarya paliurus leave powder; boiling; and carrying out the subsequent steps of curdling, marinating, pressing and forming according to the conventional methods to obtain the cyclocarya paliurus bean curd. The cyclocarya paliurus bean curd retains the original smooth and tender flavor of the bean curd, has high nutritional value and has the effects of reducing blood sugar, blood fat and blood pressure, dredging collaterals, losing weight, moisturizing skin, detoxifying and improving the immunity of the human body, thereby being the nutritional healthcare diet therapy functional bean curd which is particularly suitable for the patients with diabetes, high blood pressure and high blood fat to eat.

The invention discloses a preparation method of Radix Puerariae wine. The preparation method comprises the following steps: collecting fresh Radix Puerariae, cleaning, cutting into pieces, adding water, and performing homogenate to obtain a Radix Puerariae homogenate liquid; sterilizing the Radix Puerariae homogenate liquid at 70-110 DEG C for 5-120 minutes, cooling to 50-65 DEG C, and regulatingthe pH value to 5-7 to obtain a sterilized solution; adding amylase into the sterilized solution until the mass percentage of the amylase is 0.01-5, performing enzymolysis at 50-90 DEG C for 0.5-24 hours, adding glucoamylase until the mass percentage of the glucoamylase is 0.01-5, and performing enzymolysis at 50-70 DEG C for 4-12 hours; then increasing the temperature to 70-110 DEG C, holding the temperature for 20-150 minutes, and cooling to 20-60 DEG C to obtain an enzymolysis solution; and finally adding saccharomyces cerevisiae into the enzymolysis solution until the mass percentage of the saccharomyces cerevisiae is 0.01-0.05, fermenting at 24-40 DEG C for 5-10 days, and filtering to obtain the Radix Puerariae wine. The preparation method is simple; and the prepared Radix Puerariae wine is high in Puerarin content and has an alcohol degree of 15-35, and can be applied to adjuvant therapy for diseases such as hypertension, angina pectoris, coronary heart disease, hyperlipidemia and the like.

The invention relates to a fructus crataegi flaked candy and a preparation method of the fructus crataegi flaked candy. The flaked candy comprises, by weight, 1-40 pars of fructus crataegi powder, 5-30 parts of microcrystalline cellulose, 5-60 parts of sorbit, 5-30 parts of maltodextrin, 0.1-4 parts of lubricants and appropriate adhesion agents. Smashing, 80-mesh screening and even mixing are performed on the fructus crataegi powder and all the auxiliary materials, and then damp mass preparing, granulation, drying, granule arranging and flaking are performed to obtain the fructus crataegi candy. The fructus crataegi flaked candy has the functions of strengthening the spleen and stomach and aiding digestion, and has a certain therapeutic effect on high blood pressure, coronary disease, angor pectoris, hyperlipemia, stomachache, diarrhea and other diseases.

The invention relates to a cyclocarya paliurus tea beverage. In parts by weight, 100 parts of a cyclocarya paliurus tea beverage comprises 10 to 30 parts of cyclocarya paliurus leaves, 5 to 20 parts of green tea, 5 to 10 parts of hawthorn, 1 to 5 parts of a sweetening agent and the balance being water. A preparation method of the cyclocarya paliurus tea beverage comprises the steps of selecting materials, extracting, filtering, mixing, filling, sealing, sterilizing and cooling. Compared with pure green tea, the cyclocarya paliurus tea beverage has an extra function of reducing the high blood fat, the high blood pressure and the high blood sugar and also has certain healthcare functions; compared with pure cyclocarya paliurus tea, the cyclocarya paliurus tea beverage has a more remarkable lipid lowering effect. Compared with a conventional water extracting method, an ultrasonic multilevel countercurrent contact water extracting method adopted by the method has the advantages that the extracting rate of active ingredients can be increased by 20 to 30 percent, and certain economic benefits can be brought to enterprises. The requirement on equipment is low, the cost is low, the operability is high, the energy consumption is small, and the industrialized mass production of cyclocarya paliurus tea beverages can be realized.

The invention belongs to the technical field of food manufacturing, and discloses traditional Chinese medicine flour which is prepared from the following components in parts by weight: 150-120 parts of whole wheat powder, 60-50 parts of buckwheat powder, 20-15 parts of pea powder, 40-30 parts of sweet potato, 20-15 parts of rhizoma dioscoreae, 10-8 parts of black sesame, 20-18 parts of radish seed, 18-15 parts of fructus lycii, 16-14 parts of burdock root, 15-13 parts of folium ginkgo, 15-10 parts of radix puerariae, 12-9 parts of herba epimedii, 10-8 parts of flos chrysanthemi, 9-7 parts of uncaria rhynchophylla, 8-6 parts of eucommia ulmoides, 6-5 parts of concretio silicea bambusae, 6-5 parts of fructus crataegi, 5-4 parts of ginseng and 5-4 parts of folium mori. By eating the food prepared from the flour disclosed by the invention, the high blood pressure can be effectively controlled, and arteriosclerosis can be prevented.

The invention discloses a selenium-enriched trace element beverage and a preparation method thereof. The trace element beverage includes liquid tea beverage, coffee beverage, fruit juice beverage, soybean milk beverage, beer and drinking water added with selenium, and also includes solid tea products, Coffee products, fruit juice products, bean products, dairy products and other granulated beverages can maintain the original flavor and taste of the beverage, and at the same time have the unique anti-cancer and detoxification, anti-oxidation, anti-aging, prevention and treatment of Keshan disease, high blood pressure, Coronary heart disease, diabetes, enhance immunity, improve sperm motility, enhance liver activity, maintain heart function, remove heavy metal toxicity, accelerate detoxification and other health effects of trace element drinks. The beverage is not only suitable for daily selenium supplementation of normal people, but also suitable for intensive selenium supplementation of selenium-deficient people.

The invention discloses a capsule for treating hypertension. The capsule is characterized in that the capsule is prepared from the following traditional Chinese medicinal raw materials, by weight, 2 parts of radix astragali, 20 parts of red sage root, 6 parts of root of kudzu vine, 8 parts of Chinese yam, 10 parts of ginkgo biloba, 16 parts of corn silk, 16 parts of gynostemma pentaphylla, 7 parts of pseudo-ginseng, 35 parts of haw, 3 parts of perilla, 2 parts of apocynum venetum, 5 parts of wild chrysanthemum flower, 2 parts of prunella vulgaris, 17 parts of uncaria, 16 parts of wolfberry, 3 parts of concha haliotidis, 6 parts of eucommia, 10 parts of raw oyster shell, 15 parts of white peony root, 15 parts of achyranthes root, 3 parts of lotus plumule, 10 parts of Poria cocos, 10 parts of rhizoma alismatis and 10 parts of rhizoma gastrodiae. Symptoms of a patient can be alleviated within a short period of time after the capsule is taken. The capsule has effects of reducing blood pressure and blood lipid. Curative effect is stable; drug effect is definite; and the technology is feasible. The capsule has little side effect if a patient takes the capsule for a long time. After drug discontinuance, hypertension is not easy to recur. Costof the capsule is low.

The invention relates to an effective method of extracting puerarin and green food medicines made by it, and the steps include: using alcohol to soak, extracting several times, evaporating the alcohol, converting the extract into water solution, filtering out suspended substances; adopting polymeric absorbent to absorb, concentrating and drying and obtaining Gegen extract, by absorbing and eluting, further making flavone glycoside and terpene inner ester reach the specified indexes. Putting the extracted puerarin in drinks, beers, distilled spirits, teas, milk powders, etc; or adding the puerarin in the tablets, capsules, and electuaries or injectas. The pure plant natural food has proper taste. The Gegen is moderate, peppery and sweet, disperses the internal coldness and relieves the heat of muscle, promotes blood circulation, quenching the thirst and detoxicates alcohol toxicity, etc. and it has good curing effect on high blood pressure, coronary heart disease, heartstroke, dispels the wind, etc.

The invention relates to a preparation method of dark tea. The preparation method of the dark tea comprises the following steps of: mixing 3 to 5 parts of dark tea with the moisture content of 4.5 to 5.0 percent as well as 8 to 12 parts of mulberry leaves with the moisture content of 6.5 to 7.0 percent, 8 to 15 parts of buckwheat with the moisture content of 6.5 to 7.0 percent, 7 to 12 parts of lotus leaves with the moisture content of 6.5 to 7.0 percent, 6 to 18 parts of sweet potato leaves with the moisture content of 6.5 to 7.0 percent, 3 to 8 parts of hawthorn with the moisture content of 6.5 to 7.0 percent and 5 to 15 parts of honeysuckle with the moisture content of 6.5 to 7.0 percent, and placing the mixture into a softening tank to be softened; transferring the softened mixture to a rolling machine to be rolled for 1 to 2 min in a light-heavy-light alternating rolling manner; and transferring the rolled mixture into a green removing machine to be primarily dried, ensuring the temperature at 110 to 120 DEG, ensuring the time at 10 to 15min, initially forming the dark tea, transferring the dark tea into a fragrance enhancing machine to be stereotyped and fragrance enhanced when the fragrance is primarily presented, and forming a dark tea product. The preparation method of the dark tea product adopts a novel processing process, the raw materials are uniformly mixed, the sense of wholeness is strong, the tea streaks are compact and uniform, the color is oily and smooth, the taste is pure and fresh in drinking, the fragrance overflows, the original flavor of the tea is preserved, the dark tea is tasty and can quench the thirst after being drunk after the meal, the inflammation can be diminished, and a function for reducing the high blood pressure, hyperlipidemia and hyperglycemia and removing stubborn stool can be realized.

The invention relates to a manufacturing method for healthcare pillow pillowcase cloth. The manufacturing method is characterized by including: weaving grey cloth, and adding, by weight, 800-920 parts of water, 15-25 parts of chrysanthemum, 10-20 parts of prepared Sichuan aconite root, 5-15 parts of root of angelica dahurica, 5-15 parts of kudzuvine root, 10-20 parts of Szechuan lovage rhizome, 6-12 parts of root of red-rooted salvia and 8-16 parts of ageratum into a pressure vessel for heating at the temperature ranging from 45 DEG C to 49 DEG C prior to heat preservation for 230-270 minutes; performing final treatment. Various traditional Chinese medicine compositions of natural Chinese herbal medicine for socking a pillowcase are mixed together, so that various medical effects are multiplied and work together, for example, the chrysanthemum has the effect of dispelling wind and clearing heat and improving eyesight and detoxifying; the prepared Sichuan aconite root has the effect of dispelling wind-cold, scattering wind-evil and warming menstruation and relieving pain; the root of angelica dahurica has the effect of relieving swelling and pain and treating neurasthenia headache; the kudzuvine root has the effect of generating Yang and relaxing muscles, relieving restlessness and quenching thirst and treating high blood pressure; the Szechuan lovage rhizome has the effect of promoting circulation of Qi and relieving depression and promoting blood circulation to arrest pain. The effective components of the medicine enter a human body by means of skin penetration, acupuncture point absorption, meridian transmission and the like.